Physician profile
Melissa Ries
NPI 1790195964
$1,944.70
in general payments reported to CMS, 2019-2025
25 companies · $16.13 in 2025
The $16.13 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $1,004 · 2021: $127 · 2022: $83.70 · 2023: $426 · 2024: $175 · 2025: $16.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $861.84 | 2020 | |
| Orthofix Medical, INC. | $400.93 | 2019-2024 | Physio-Stim, Spinal-Stim |
| Abbott Laboratories | $71.08 | 2021-2023 | Assurity, Eterna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.42 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $61.30 | 2024 | Dupixent |
| Stryker Corporation | $50.04 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $49.62 | 2023 | Seglentis |
| Integra Lifesciences Corporation | $38.02 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Melinta Therapeutics, LLC | $35.37 | 2019 | |
| Biogen, INC. | $30.04 | 2022 | |
| Goode Surgical INC | $29.68 | 2019 | |
| Advanced Oxygen Therapy INC. | $26.61 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Mylan Specialty L.P. | $24.79 | 2024 | Yupelri |
| Pfizer INC. | $22.60 | 2024 | |
| Baxter Healthcare | $22.53 | 2024 | Hillrom - Vest System Model 105 Home Care |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $18.90 | 2022 | |
| Nevro Corp. | $18.75 | 2022 | |
| Smith+Nephew, INC. | $18.27 | 2019 | |
| Zealand Pharma US, INC. | $18.05 | 2021 | |
| Lucid Diagnostics INC. | $16.01 | 2022 | |
| Tactile Systems Technology INC | $12.95 | 2023 | Entre Plus, Flexitouch Plus |
| Grt US Holding, INC. | $12.21 | 2021 | |
| Insulet Corporation | $11.72 | 2021 | |
| Novo Nordisk INC | $11.70 | 2020 | |
| Misonix INC | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Ries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.